0001209191-21-023367.txt : 20210326
0001209191-21-023367.hdr.sgml : 20210326
20210326214826
ACCESSION NUMBER: 0001209191-21-023367
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210208
FILED AS OF DATE: 20210326
DATE AS OF CHANGE: 20210326
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ABERNETHY MATT
CENTRAL INDEX KEY: 0001724097
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22705
FILM NUMBER: 21779290
MAIL ADDRESS:
STREET 1: C/O NEUROCRINE BIOSCIENCES, INC.
STREET 2: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC
CENTRAL INDEX KEY: 0000914475
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330525145
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 617-7600
MAIL ADDRESS:
STREET 1: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2021-02-08
2021-02-09
0
0000914475
NEUROCRINE BIOSCIENCES INC
NBIX
0001724097
ABERNETHY MATT
12780 EL CAMINO REAL
SAN DIEGO
CA
92130
0
1
0
0
Chief Financial Officer
Stock Option
117.63
2021-02-08
4
A
0
49049
0.00
A
2031-02-08
Common Stock
49049
49049
D
Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 8, 2021 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter.
This amendment is being filed to correct a change in the number of shares in the option grant reported in Table II on the reporting person's original Form 4 filed February 9, 2021.
/s/ Darin Lippoldt, Attorney-in-Fact
2021-03-26